257 related articles for article (PubMed ID: 31498516)
1. Masked hypertensives: A disguised arterial stiffness population.
Antza C; Doundoulakis I; Stabouli S; Tziomalos K; Kotsis V
J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1473-1480. PubMed ID: 31498516
[TBL] [Abstract][Full Text] [Related]
2. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
[TBL] [Abstract][Full Text] [Related]
3. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
[TBL] [Abstract][Full Text] [Related]
4. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
[TBL] [Abstract][Full Text] [Related]
6. Long-term risk of sustained hypertension in white-coat or masked hypertension.
Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Polo Friz H; Grassi G; Sega R
Hypertension; 2009 Aug; 54(2):226-32. PubMed ID: 19564548
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical outcomes of white-coat and masked hypertension: Analysis of a large ambulatory blood pressure database.
Tocci G; Presta V; Figliuzzi I; Attalla El Halabieh N; Battistoni A; Coluccia R; D'Agostino M; Ferrucci A; Volpe M
J Clin Hypertens (Greenwich); 2018 Feb; 20(2):297-305. PubMed ID: 29370477
[TBL] [Abstract][Full Text] [Related]
8. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement.
Matsui Y; Eguchi K; Ishikawa J; Hoshide S; Shimada K; Kario K
Am J Hypertens; 2007 Apr; 20(4):385-91. PubMed ID: 17386344
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Assessment of Myocardial Perfusion in Different Blood Pressure Phenotypes and Its Association With Arterial Stiffness Indices.
Anyfanti P; Gkaliagkousi E; Triantafyllou A; Dipla K; Zarifis H; Arseniou P; Lazaridis A; Douma S
Am J Hypertens; 2019 May; 32(6):557-563. PubMed ID: 30877305
[TBL] [Abstract][Full Text] [Related]
10. Arterial stiffness in children and adolescents with masked and sustained hypertension.
Kollios K; Nika T; Kotsis V; Chrysaidou K; Antza C; Stabouli S
J Hum Hypertens; 2021 Jan; 35(1):85-93. PubMed ID: 32099080
[TBL] [Abstract][Full Text] [Related]
11. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D
Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis.
Karnjanapiboonwong A; Anothaisintawee T; Chaikledkaew U; Dejthevaporn C; Attia J; Thakkinstian A
BMC Cardiovasc Disord; 2020 Nov; 20(1):491. PubMed ID: 33225900
[TBL] [Abstract][Full Text] [Related]
13. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.
Sivén SS; Niiranen TJ; Kantola IM; Jula AM
J Hypertens; 2016 Jan; 34(1):54-60. PubMed ID: 26630213
[TBL] [Abstract][Full Text] [Related]
14. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease.
Wang C; Zhang J; Li Y; Ma X; Ye Z; Peng H; Lou T
Int J Cardiol; 2017 Mar; 230():33-39. PubMed ID: 28034462
[TBL] [Abstract][Full Text] [Related]
15. Hypertension defined by the 2017 ACC/AHA guideline is more accurate than 2018 ESC/ESH for detecting early vascular aging in young adults.
de Souza MP; Lopes PC; Bazo G; Rocha PRH; Lorencini DA; Bettiol H; Barbieri MA; Coelho EB
Medicine (Baltimore); 2022 Feb; 101(6):e28841. PubMed ID: 35147130
[TBL] [Abstract][Full Text] [Related]
16. Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.
Ghazi L; Cohen LP; Muntner P; Shimbo D; Drawz PE
Hypertension; 2020 Oct; 76(4):1090-1096. PubMed ID: 32829666
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal hypertension: poor correlation with office blood pressure but strong prognostic factor for target organ damage.
Chatzistamatiou EI; Moustakas GN; Veioglanis S; Papoutsis D; Memo G; Tsioufis C; Avgeropoulou A; Stefanadis C; Kallikazaros I
Hellenic J Cardiol; 2012; 53(4):263-72. PubMed ID: 22796813
[TBL] [Abstract][Full Text] [Related]
18. Ambulatory blood pressure monitoring parameters in obese children and adolescents with masked hypertension.
Yegül-Gülnar G; Kasap-Demir B; Alparslan C; Çatli G; Mutlubaş F; Yavaşcan Ö; Özkan B; Dündar BN; Aksu N
Blood Press Monit; 2019 Dec; 24(6):277-283. PubMed ID: 31567187
[TBL] [Abstract][Full Text] [Related]
19. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension.
Afsar B
J Cardiol; 2013 Mar; 61(3):222-6. PubMed ID: 23294898
[TBL] [Abstract][Full Text] [Related]
20. Office blood pressure is a predictor of aortic elastic properties and urinary protein excretion in subjects with white coat hypertension.
Aznaouridis K; Vlachopoulos C; Masoura K; Pietri P; Vyssoulis G; Ioakeimidis N; Stefanadis C; Tousoulis D
Int J Cardiol; 2016 Jan; 203():98-103. PubMed ID: 26498870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
